| Gene symbol | CLDN18 | Synonyms | SFTA5, SFTPJ | Type of gene | protein-coding |
| Chromosome | 3 | Map location | 3q22.3 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | claudin 18 | ||||
| GTO ID | GTC2899 |
| Trial ID | NCT05199519 |
| Disease | Solid Tumor |
| Altered gene | CLDN18 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | IBI345 |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | Study to Evaluate the Safety, Tolerance, Pharmacokinetics and Preliminary Efficacy of IBI345 |
| Year | 2022 |
| Country | China |
| Company sponsor | Innovent Biologics (Suzhou) Co. Ltd. |
| Other ID(s) | CIBI345Y001 |
| Cohort 1 | |||||||
|
|||||||